Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-11-052629
Filing Date
2011-10-25
Accepted
2011-10-25 16:34:30
Documents
1
Period of Report
2011-10-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6762
  Complete submission text file 0001209191-11-052629.txt   8121
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850 240-599-4500
Vanda Pharmaceuticals Inc. (Issuer) CIK: 0001347178 (see all company filings)

EIN.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1410 PARSONS LANE AMBLER PA 19002
Business Address
Repella Robert (Reporting) CIK: 0001532513 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34186 | Film No.: 111157036